KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) Equity Ratio: 2018-2025

Historic Equity Ratio for Twist Bioscience (TWST) over the last 7 years, with Sep 2025 value amounting to 0.74.

  • Twist Bioscience's Equity Ratio fell 4.24% to 0.74 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.74, marking a year-over-year decrease of 4.24%. This contributed to the annual value of 0.74 for FY2025, which is 4.24% down from last year.
  • Twist Bioscience's Equity Ratio amounted to 0.74 in Q3 2025, which was down 0.83% from 0.74 recorded in Q2 2025.
  • Over the past 5 years, Twist Bioscience's Equity Ratio peaked at 0.91 during Q1 2021, and registered a low of 0.74 during Q3 2025.
  • For the 3-year period, Twist Bioscience's Equity Ratio averaged around 0.78, with its median value being 0.77 (2024).
  • Examining YoY changes over the last 5 years, Twist Bioscience's Equity Ratio showed a top increase of 11.16% in 2021 and a maximum decrease of 12.66% in 2021.
  • Twist Bioscience's Equity Ratio (Quarterly) stood at 0.80 in 2021, then climbed by 2.97% to 0.82 in 2022, then dropped by 1.83% to 0.81 in 2023, then declined by 6.95% to 0.75 in 2024, then fell by 4.24% to 0.74 in 2025.
  • Its Equity Ratio was 0.74 in Q3 2025, compared to 0.74 in Q2 2025 and 0.74 in Q1 2025.